Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease

Trial Profile

Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Jun 2018

At a glance

  • Drugs OC-02 (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Oyster Point Pharmaceuticals
  • Most Recent Events

    • 27 Jun 2018 According to an Oyster Point Pharma media release, data from this trial will be presented at an upcoming medical meeting.
    • 13 Jun 2018 Status changed from active, no longer recruiting to completed.
    • 17 Apr 2018 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top